XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF CASH AND CASH EQUIVALENTS AND INVESTMENTS (Details) - USD ($)
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2022
Impairment Effects on Earnings Per Share [Line Items]      
Cash and Cash Equivalents $ 3,928,836 $ 5,619,083 $ 10,644,751
Cash [Member]      
Impairment Effects on Earnings Per Share [Line Items]      
Cost 673,118 242,271  
Cash and Cash Equivalents 673,118 242,271  
Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]      
Impairment Effects on Earnings Per Share [Line Items]      
Cost 3,255,718 5,376,812  
Cash and Cash Equivalents 3,255,718 5,376,812  
Fair Value 3,255,718 5,376,812  
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]      
Impairment Effects on Earnings Per Share [Line Items]      
Cost 3,928,836 5,619,083  
Cash and Cash Equivalents 3,928,836 5,619,083  
Fair Value $ 3,255,718 $ 5,376,812